Valuation: Terumo Corporation

Market Cap 3,388B 21.56B 18.99B 17.99B 16.24B 30.61B 2,067B 31B 215B 82.83B 1,057B 80.96B 79.2B P/E 2027 *
17.8x
P/E 2028 * 17.6x
Enterprise Value 3,434B 21.85B 19.24B 18.23B 16.46B 31.02B 2,095B 31.43B 218B 83.95B 1,071B 82.06B 80.27B EV / Sales 2027 *
2.72x
EV / Sales 2028 * 2.51x
Free-Float
97.34%
Yield 2027 *
1.61%
Yield 2028 * 1.74%
1 day-6.99%
1 week-2.36%
1 month-9.63%
3 months+2.35%
6 months+9.06%
Current year+2.49%
1 week 13.5
Extreme 13.5
15.45
1 month 13.5
Extreme 13.5
15.48
Current year 11.49
Extreme 11.49
17.01
1 year 11.49
Extreme 11.49
18.6
3 years 11.49
Extreme 11.49
22.26
5 years 11.49
Extreme 11.49
23.46
10 years 11.49
Extreme 11.49
30.1
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
-6.99%-2.36% - - 21.31B
-2.10%-4.50%-26.21%+2.04% 175B
-0.92%-3.37%-9.40%+10.12% 111B
-0.90%+0.73%-25.50%+0.78% 107B
+0.69%-2.90%-47.25%-11.84% 75.31B
-2.39%-3.85%-3.93%+66.83% 58.7B
-1.63%-1.93%-4.37%-30.76% 49.57B
+1.46%+3.44%+16.30%+57.88% 49.27B
-2.11%+0.03%-18.27%+19.42% 42.02B
-0.40%-1.64%+28.24%-7.51% 32.69B
Average -1.09%-1.63%-10.04%+11.88% 77.84B
Weighted average by Cap. -0.22%-2.20%-16.27%+9.27%

Financials

2027 *2028 *
Net sales 1,261B 8.02B 7.06B 6.69B 6.04B 11.39B 769B 11.53B 80.07B 30.81B 393B 30.12B 29.46B 1,342B 8.54B 7.52B 7.12B 6.43B 12.12B 819B 12.28B 85.22B 32.79B 418B 32.06B 31.36B
Net income 191B 1.21B 1.07B 1.01B 913M 1.72B 116B 1.74B 12.1B 4.66B 59.42B 4.55B 4.45B 193B 1.23B 1.08B 1.02B 924M 1.74B 118B 1.76B 12.25B 4.71B 60.13B 4.61B 4.51B
Net Debt 45.99B 293M 258M 244M 220M 415M 28.06B 421M 2.92B 1.12B 14.35B 1.1B 1.07B -26.39B -168M -148M -140M -127M -238M -16.1B -242M -1.68B -645M -8.23B -631M -617M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
26-09-30 US$13.50 -6.99% 590
26-09-28 US$14.52 +4.98% 2,373
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,297.00JPY
Average target price
3,110.00JPY
Spread / Average Target
+35.39%

Quarterly revenue - Rate of surprise